Editas Medicine, Inc. (EDIT)

Editas Medicine Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	69.41	78.12	19.71	25.54	90.73	20.53
Revenue Growth (YoY)	204.52%	296.32%	-22.83%	-71.85%	341.93%	-35.71%
Cost of Revenue	188.63	177.65	174.96	142.51	158	96.9
Gross Profit	-119.23	-99.53	-155.25	-116.96	-67.26	-76.37
Selling, General & Admin	65.98	69.65	70.7	76.18	67.58	64.56
Operating Expenses	65.98	69.65	70.7	76.18	67.58	64.56
Operating Income	-185.21	-169.18	-225.95	-193.15	-134.84	-140.92
Interest & Investment Income	19.09	17.57	5.52	0.61	2.61	7.31
Other Non Operating Income (Expenses)	1.59	-	-	0.04	-0.11	-0.14
EBT Excluding Unusual Items	-164.53	-151.62	-220.43	-192.5	-132.34	-133.75
Gain (Loss) on Sale of Investments	-1.6	-1.6	-	-	16.37	-
Pretax Income	-166.13	-153.22	-220.43	-192.5	-115.98	-133.75
Net Income	-166.13	-153.22	-220.43	-192.5	-115.98	-133.75
Net Income to Common	-166.13	-153.22	-220.43	-192.5	-115.98	-133.75
Shares Outstanding (Basic)	79	76	69	68	59	50
Shares Outstanding (Diluted)	79	76	69	68	59	50
Shares Change (YoY)	15.19%	10.63%	1.55%	15.37%	17.26%	6.13%
EPS (Basic)	-2.10	-2.02	-3.21	-2.85	-1.98	-2.68
EPS (Diluted)	-2.10	-2.02	-3.21	-2.85	-1.98	-2.68
Free Cash Flow	-151.03	-136.9	-181.47	-171.78	-187.01	-46.84
Free Cash Flow Per Share	-1.91	-1.80	-2.64	-2.54	-3.19	-0.94
Gross Margin	-171.78%	-127.40%	-	-	-74.13%	-
Operating Margin	-266.85%	-216.56%	-1146.26%	-756.13%	-148.61%	-686.39%
Profit Margin	-239.36%	-196.13%	-	-	-127.82%	-
Free Cash Flow Margin	-217.60%	-175.23%	-920.59%	-672.49%	-206.11%	-228.12%
EBITDA	-179.28	-163.12	-219.61	-188.09	-130.88	-138.09
EBITDA Margin	-258.31%	-208.80%	-	-	-144.25%	-
D&A For EBITDA	5.93	6.06	6.34	5.05	3.96	2.83
EBIT	-185.21	-169.18	-225.95	-193.15	-134.84	-140.92
EBIT Margin	-266.85%	-216.56%	-	-	-148.61%	-

Source: S&P Capital IQ. Standard template.